To test potential interactions between FLLL32 or FLLL62 and STAT1 in a biologic system, we investigated the effects of pre-treatment with these inhibitors on IFN-γ-induced signaling and gene expression of representative metastatic human RCC and melanoma cell lines. The gene discussed is STAT1; the disease is melanoma.